GFAP and brain inflammatory disease: Compared to controls (0.1% BSA in 0.9% NaCl), a significant increase of genes related with glia activation (Gfap and Cd68 but not Iba1) but not with brain inflammation (Il-6, Il-1β) was observed at 24 h post-injection.